Breast cancer risk and "delayed" primary Epstein-Barr virus infection

被引:0
作者
Yasui, Y
Potter, JD
Stanford, JL
Rossing, MA
Winget, MD
Bronner, M
Daling, J
机构
[1] Fred Hutchinson Canc Res Ctr, Canc Prevent Res Proram, Seattle, WA 98109 USA
[2] Fred Hutchinson Canc Res Ctr, Program Epidemiol, Seattle, WA 98109 USA
[3] Univ Washington, Dept Pathol, Seattle, WA 98103 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Parallel to its established causal association with both infectious mononucleosis (IM) and young adulthood Hodgkin disease (YAHD), we propose a hypothesis that "delayed" primary EBV infection (i.e., primary infection occurring during adolescence or adulthood) is associated with elevated breast cancer risk. We evaluated this hypothesis with two investigations, one descriptive and the other analytic. The descriptive study used international/United States cancer registry data to assess the association between incidence rates of breast cancer and those of YAHD, The incidence rates of the seemingly unrelated neoplasms were strongly correlated (correlation coefficients of 0.74 and 0.88 for international and United States data, respectively; these were higher than the correlation coefficients of YAHD with two other cancers that we considered). Populations with higher incidence rates corresponded to those with higher likelihood of delayed primary EBV infection. The analytical study was based on a population-based case-control study of breast cancer in middle-aged women, Age-adjusted odds ratios of breast cancer in women who reported a history of IM, relative to women who did not, increased monotonically from 0.55 [95% confidence interval (CI), 0.05-6.17] for women with 0-9 years of age at IM onset to 2.67 (CI, 1.04-6.89) for women with greater than or equal to 25 years of age at IM onset (P = 0.016), An older age at tonsillectomy, another surrogate of delayed EBV exposure, was also associated with increased risk of breast cancer: odds ratios, 0.92 (CI, 0.57-1.48) and 1.76 (CI, 1.15-2.69) for women with tonsillectomy at 0-4 years of age and greater than or equal to 15 years of age, respectively (P = 0.018), Adjusting for additional potential confounders did not modify the associations appreciably. The implications of the findings and a potential biological mechanism are presented.
引用
收藏
页码:9 / 16
页数:8
相关论文
共 50 条
[41]   Kawasaki disease with a concomitant primary Epstein-Barr virus infection [J].
Rosenfeld, Nataly ;
Tasher, Diana ;
Ovadia, Adi ;
Abiri, Shirly ;
Dalal, Ilan .
PEDIATRIC RHEUMATOLOGY, 2020, 18 (01)
[42]   Primary Epstein-Barr virus infection with polyradiculitis: a case report [J].
Tilmann Hottenrott ;
Sebastian Rauer ;
Jochen Bäuerle .
BMC Neurology, 13
[43]   Primary Epstein-Barr virus infection with polyradiculitis: a case report [J].
Hottenrott, Tilmann ;
Rauer, Sebastian ;
Baeuerle, Jochen .
BMC NEUROLOGY, 2013, 13
[44]   Acute Dacryoadenitis due to Primary Epstein-Barr Virus Infection [J].
Hayano, Satoshi ;
Nakada, Naruhiko ;
Kashima, Masayuki .
OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (04)
[45]   Vaginal ulceration as the presentation of primary Epstein-Barr virus infection [J].
Fett, Nicole ;
Hinshaw, Molly .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) :AB93-AB93
[46]   KAWASAKI DISEASE AND AN UNUSUAL PRIMARY INFECTION WITH EPSTEIN-BARR VIRUS [J].
KIKUTA, H ;
MIZUNO, F ;
OSATO, T ;
KONNO, M ;
ISHIKAWA, N ;
NORO, SI ;
SAKURADA, N .
PEDIATRICS, 1984, 73 (03) :413-414
[47]   Jaundice as a Rare Manifestation of Epstein-Barr Virus Primary Infection [J].
Santos, Ligia Rodrigues ;
Cruz, Margarida Silva ;
Ferraz, Rita Veiga ;
Moreira, Vera Ferraz ;
Castro, Alice .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (06)
[48]   Epstein-Barr virus infection. [J].
Cohen, JI .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (07) :481-492
[49]   Epstein-Barr virus infection mechanisms [J].
Chesnokova, Liudmila S. ;
Hutt-Fletcher, Lindsey M. .
CHINESE JOURNAL OF CANCER, 2014, 33 (11) :545-548
[50]   Genetics of Epstein-Barr virus infection [J].
Hiraki, A ;
Fujii, N ;
Masuda, K ;
Ikeda, K ;
Tanimoto, M .
BIOMEDICINE & PHARMACOTHERAPY, 2001, 55 (07) :369-372